Segundo Buján
Impact in
- Immunology top 10%
- Immune Response and Inflammation
- IL-33, ST2, and ILC Pathways
- interferon and immune responses
- Rheumatology top 5%
- Systemic Lupus Erythematosus Research
Papers in
-
- Systemic Lupus Erythematosus Research 5
-
- Atherosclerosis and Cardiovascular Diseases 2
- Co-authors
- Juan I. Aróstegui (3 shared papers)Jordi Yagüe (3 shared papers)Pablo Pelegrı́n (2 shared papers)Jordi Antón (1 shared paper)David Brough (1 shared paper)J. Amores (1 shared paper)Ana Isabel Gómez Córdoba (1 shared paper)Isabelle Couillin (1 shared paper)
- Journals
- Annals of the Rheumatic Diseases (3 papers)Arthritis & Rheumatology (1 paper)Nature Immunology (1 paper)Clinical and Experimental Rheumatology (1 paper)Lara D. Veeken (1 paper)
- Partner nations
- SpainUnited KingdomFrance
In The Last Decade
Segundo Buján
11 papers receiving 941 citations
Segundo Buján's Hit Papers
Peers
Comparison fields: 5 of 82
- Immunology 365
- Rheumatology 187
- Nephrology 79
- Biological Psychiatry 27
- Molecular Biology 523
Countries citing papers authored by Segundo Buján
This map shows the geographic impact of Segundo Buján's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Segundo Buján with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Segundo Buján more than expected).
Fields of papers citing papers by Segundo Buján
This network shows the impact of papers produced by Segundo Buján. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Segundo Buján. The network helps show where Segundo Buján may publish in the future.
Co-authors
The 25 scholars most cited alongside Segundo Buján, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | The NLRP3 inflammasome is released as a particulate danger signal that amplifies the inflammatory response Hit paper breakdown → | 2014 | 645 |
| 2 | 2004 | 75 | |
| 3 | Thalidomide in the treatment of cutaneous lupus refractory to conventional therapy. | 2000 | 63 |
| 4 | 2016 | 57 | |
| 5 | 2003 | 46 | |
| 6 | 2021 | 22 | |
| 7 | 1997 | 20 | |
| 8 | 2021 | 17 | |
| 9 | 2002 | 9 | |
| 10 | 2018 | 1 | |
| 11 | 2024 | 1 | |
| 12 | 2014 | 0 |
About Segundo Buján
Segundo Buján is a scholar working on Rheumatology, Immunology, Molecular Biology, Pulmonary and Respiratory Medicine and Infectious Diseases, having authored 12 papers that have together received 956 indexed citations. Recurring topics across this work include Systemic Lupus Erythematosus Research (5 papers), Inflammasome and immune disorders (3 papers), Atherosclerosis and Cardiovascular Diseases (2 papers), Ocular Diseases and Behçet’s Syndrome (1 paper), Systemic Sclerosis and Related Diseases (1 paper), Salivary Gland Disorders and Functions (1 paper), Infectious Disease Case Reports and Treatments (1 paper) and Gastrointestinal disorders and treatments (1 paper). The work is most often cited by research in Immunology (365 citations), Rheumatology (187 citations), Nephrology (79 citations), Biological Psychiatry (27 citations) and Molecular Biology (523 citations). Segundo Buján has collaborated with scholars based in Spain, United Kingdom and France. Frequent co-authors include Juan I. Aróstegui, Jordi Yagüe, Pablo Pelegrı́n, Jordi Antón, David Brough, J. Amores, Ana Isabel Gómez Córdoba, Isabelle Couillin, María Barberà-Cremades and Fatima Martín‐Sánchez. Their work appears in journals such as Annals of the Rheumatic Diseases, Arthritis & Rheumatology, Nature Immunology, Clinical and Experimental Rheumatology and Lara D. Veeken.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.